MAGT1 is required for HeLa cell proliferation through regulating p21 expression, S-phase progress, and ERK/p38 MAPK MYC axis

References

• Goytain A, Quamme GA. Identification and characterization of a novel mammalian Mg2+ transporter with channel-like properties. BMC Genomics. 2005;6:48.
   PubMed Web of Science ®Google Scholar
• Quamme GA. Molecular identification of ancient and modern mammalian magnesium transporters. Am J Physiol Cell Physiol. 2010;298(3):C407–429.
   PubMed Web of Science ®Google Scholar
• Brigida I, Chiriaco M, Di Cesare S, et al. Large deletion of MAGT1 gene in a patient with classic kaposi sarcoma, CD4 lymphopenia, and EBV infection. J Clin Immunol. 2017;37(1):32–35.
   PubMed Web of Science ®Google Scholar
• Li FY, Lenardo MJ, Chaigne-Delalande B. Loss of MAGT1 abrogates the Mg2+ flux required for T cell signaling and leads to a novel human primary immunodeficiency. Magnes Res. 2011;24(3):S109–114.
   PubMed Web of Science ®Google Scholar
• Blommaert E, Peanne R, Cherepanova NA, et al. Mutations in MAGT1 lead to a glycosylation disorder with a variable phenotype. Proc Natl Acad Sci U S A. 2019;116(20):9865–9870.
   PubMed Web of Science ®Google Scholar
• Trapani V, Shomer N, Rajcan-Separovic E. The role of MAGT1 in genetic syndromes. Magnes Res. 2015;28(2):46–55.
   PubMed Web of Science ®Google Scholar
• Qiao Y, Mondal K, Trapani V, et al. Variant ATRX syndrome with dysfunction of ATRX and MAGT1 genes. Hum Mutat. 2014;35(1):58–62.
   PubMed Web of Science ®Google Scholar
• Matsuda-Lennikov M, Biancalana M, Zou J, et al. Magnesium transporter 1 (MAGT1) deficiency causes selective defects in N-linked glycosylation and expression of immune-response genes. J Biol Chem. 2019;294(37):13638–13656.
   PubMed Web of Science ®Google Scholar
• Zheng J, Mao X, Ling J, et al. Role of magnesium transporter subtype 1 (MagT1) in the osteogenic differentiation of rat bone marrow stem cells. Biol Trace Elem Res. 2016;171(1):131–137.
   PubMed Web of Science ®Google Scholar
• Castiglioni S, Romeo V, Locatelli L, et al. The simultaneous downregulation of TRPM7 and MagT1 in human mesenchymal stem cells in vitro: effects on growth and osteogenic differentiation. Biochem Biophys Res Commun. 2019;513(1):159–165.
   PubMed Web of Science ®Google Scholar
• Xun Q, Bi C, Cui X, et al. MagT1 is essential for Drosophila development through the shaping of Wingless and Decapentaplegic signaling pathways. Biochem Biophys Res Commun. 2018;503(2):1148–1153.
   PubMed Web of Science ®Google Scholar
• Zheng JM, Kong YY, Li YY, et al. MagT1 regulated the odontogenic differentiation of BMMSCs induced byTGC-CM via ERK signaling pathway. Stem Cell Res Ther. 2019;10(1):48.
   PubMedGoogle Scholar
• Zheng K, Yang Q, Xie L, et al. Overexpression of MAGT1 is associated with aggressiveness and poor prognosis of colorectal cancer. Oncol Lett. 2019;18(4):3857–3862.
   PubMed Web of Science ®Google Scholar
• Molee P, Adisakwattana P, Reamtong O, et al. Up-regulation of AKAP13 and MAGT1 on cytoplasmic membrane in progressive hepatocellular carcinoma: a novel target for prognosis. Int J Clin Exp Pathol. 2015;8(9):9796–9811.
   PubMed Web of Science ®Google Scholar
• Malumbres M, Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer. 2009;9(3):153–166.
   PubMed Web of Science ®Google Scholar
• Aleem E, Kiyokawa H, Kaldis P. Cdc2-cyclin E complexes regulate the G1/S phase transition. Nat Cell Biol. 2005;7(8):831–U893.
   PubMed Web of Science ®Google Scholar
• Pagano M, Pepperkok R, Verde F, et al. Cyclin A is required at two points in the human cell cycle. EMBO J. 1992;11(3):961–971.
   PubMed Web of Science ®Google Scholar
• Girard F, Strausfeld U, Fernandez A, et al. Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell. 1991;67(6):1169–1179.
   PubMed Web of Science ®Google Scholar
• Radhakrishnan SK, Feliciano CS, Najmabadi F, et al. Constitutive expression of E2F-1 leads to p21-dependent cell cycle arrest in S phase of the cell cycle. Oncogene. 2004;23(23):4173–4176.
   PubMed Web of Science ®Google Scholar
• Bunz F, Dutriaux A, Lengauer C, et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science. 1998;282(5393):1497–1501.
   PubMed Web of Science ®Google Scholar
• Bertoli C, Skotheim JM, De Bruin RA. Control of cell cycle transcription during G1 and S phases. Nat Rev Mol Cell Biol. 2013;14(8):518–528.
   PubMed Web of Science ®Google Scholar
• Gartel AL, Shchors K. Mechanisms of c-myc-mediated transcriptional repression of growth arrest genes. Exp Cell Res. 2003;283(1):17–21.
   PubMed Web of Science ®Google Scholar
• Gartel AL, Ye X, Goufman E, et al. Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3. Proc Natl Acad Sci U S A. 2001;98(8):4510–4515.
   PubMed Web of Science ®Google Scholar
• Macleod KF, Sherry N, Hannon G, et al. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev. 1995;9(8):935–944.
   PubMed Web of Science ®Google Scholar
• El-deiry WS, Tokino T, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell. 1993;75(4):817–825.
   PubMed Web of Science ®Google Scholar
• Sun Y, Liu WZ, Liu T, et al. Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis. J Recept Signal Transduct Res. 2015;35(6):600–604.
   PubMed Web of Science ®Google Scholar
• Gramling MW, Eischen CM. Suppression of Ras/Mapk pathway signaling inhibits Myc-induced lymphomagenesis. Cell Death Differ. 2012;19(7):1220–1227.
   PubMed Web of Science ®Google Scholar
• Roux PP, Blenis J. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev. 2004;68(2):320–344.
   PubMed Web of Science ®Google Scholar
• Sears R, Nuckolls F, Haura E, et al. Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev. 2000;14(19):2501–2514.
   PubMed Web of Science ®Google Scholar
• Kim EK, Choi EJ. Pathological roles of MAPK signaling pathways in human diseases. Biochim Biophys Acta. 2010;1802(4):396–405.
   PubMed Web of Science ®Google Scholar
• Caunt CJ, Keyse SM. Dual-specificity MAP kinase phosphatases (MKPs): shaping the outcome of MAP kinase signalling. FEBS J. 2013;280(2):489–504.
   PubMed Web of Science ®Google Scholar
• Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science. 2002;298(5600):1911–1912.
   PubMed Web of Science ®Google Scholar
• Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature. 2001;410(6824):37–40.
   PubMed Web of Science ®Google Scholar
• Bhalla US, Ram PT, Iyengar R. MAP kinase phosphatase as a locus of flexibility in a mitogen-activated protein kinase signaling network. Science. 2002;297(5583):1018–1023.
   PubMed Web of Science ®Google Scholar
• Ceballos E, Delgado MD, Gutierrez P, et al. c-Myc antagonizes the effect of p53 on apoptosis and p21WAF1 transactivation in K562 leukemia cells. Oncogene. 2000;19(18):2194–2204.
   PubMed Web of Science ®Google Scholar
• Gu W, Putral L, Hengst K, et al. Inhibition of cervical cancer cell growth in vitro and in vivo with lentiviral-vector delivered short hairpin RNA targeting human papillomavirus E6 and E7 oncogenes. Cancer Gene Ther. 2006;13(11):1023–1032.
   PubMed Web of Science ®Google Scholar
• Pal A, Kundu R. Human papillomavirus E6 and E7: the cervical cancer hallmarks and targets for therapy. Front Microbiol. 2019;10:3116.
   PubMed Web of Science ®Google Scholar
• Nishida H, Matsumoto Y, Kawana K, et al. Systemic delivery of siRNA by actively targeted polyion complex micelles for silencing the E6 and E7 human papillomavirus oncogenes. J Control Release. 2016;231:29–37.
   PubMed Web of Science ®Google Scholar
• de Baaij JH, Hoenderop JG, Bindels RJ. Magnesium in man: implications for health and disease. Physiol Rev. 2015;95(1):1–46.
   PubMed Web of Science ®Google Scholar
• Malanchi I, Caldeira S, Krutzfeldt M, et al. Identification of a novel activity of human papillomavirus type 16 E6 protein in deregulating the G1/S transition. Oncogene. 2002;21(37):5665–5672.
   PubMed Web of Science ®Google Scholar
• Martin LG, Demers GW, Galloway DA. Disruption of the G1/S transition in human papillomavirus type 16 E7-expressing human cells is associated with altered regulation of cyclin E. J Virol. 1998;72(2):975–985.
   PubMed Web of Science ®Google Scholar